EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:
“How can we ensure cancer treatments truly benefit patients, not just meet regulatory benchmarks?
In his latest feature with the European Cancer Organisation, our CEO, Denis Lacombe, explores why treatment optimisation is essential for improving access to better cancer care across Europe. From de-escalation studies to policy reform, discover how EORTC is driving change through independent, patient-focused research.
More posts featuring EORTC.